Montelukast does not appear to increase the risk for neuropsychiatric adverse events in children and adolescents, according to a study published in JAMA Pediatrics. Montelukast is a leukotriene ...
Be honest and relatable: build a deeper connection by being transparent about your goals. For example: ‘We’re really trying to grow our practice with wonderful patients like you, and your support ...
(NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced two ...